Trials / Completed
CompletedNCT02232607
Efficacy and Safety of Lacidipine in Chronic Stable Angina
A Randomised, Double-blind, Placebo-controlled, Multi-centre, Parallel Group, Dose Ranging Study to Investigate the Efficacy and Safety of Lacidipine in Chronic Stable Angina.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 283 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study was to explore whether lacidipine at doses of 2 mg, 4 mg and 6 mg decreased the symptoms of angina, compared to placebo in patients with chronic stable angina
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lacidipine, low dose | |
| DRUG | Lacidipine, medium dose | |
| DRUG | Lacidipine, high dose | |
| DRUG | Placebo |
Timeline
- Start date
- 1998-04-01
- Primary completion
- 1999-06-01
- First posted
- 2014-09-05
- Last updated
- 2014-09-05
Source: ClinicalTrials.gov record NCT02232607. Inclusion in this directory is not an endorsement.